Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis

Wei Ding, Tait D. Shanafelt, Connie E. Lesnick, Charles Erlichman, Jose F. Leis, Charla Secreto, Traci R. Sassoon, Timothy G. Call, Deborah A. Bowen, Michael Conte, Shaji Kumar, Neil E. Kay

Research output: Contribution to journal › Letter › peer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis'. Together they form a unique fingerprint.